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Background: Over the past four decades, extraordinary progress has been made in establishing and improving
childhood immunization programmes around Africa. In order to ensure effective and sustainable positive growth of
these childhood immunisations programmes, the development, adaptation and implementation of all interventions
(programme activities, new vaccines, new strategies and policies) should be informed by the best available local
evidence.
Methods: An assessment of the peer-reviewed literature on childhood immunization research published in English
from 1970 to 2010 was conducted in PubMed and Africa-Wide databases. All study types were eligible for inclusion.
A standard form was used to extract information from all studies identified as relevant and entered into a Microsoft
Access database for analysis.
Results: Our initial search yielded 5436 articles from the two databases, from which 848 full text articles were
identified as relevant. Among studies classified as clinical research (417), 40% were clinical trials, 24% were burden
of disease/epidemiology and 36% were other clinical studies. Among studies classified as operational research (431),
77% related to programme management, 18% were policy related and 5% were related to vaccine financing.
Studies were conducted in 48 African countries with six countries (South Africa, The Gambia, Nigeria, Senegal,
Guinea-Bissau and Kenya) accounting for 56% of the total research output. Studies were published in 152 different
journals with impact factors ranging from 0.192 to 53.29; with a median impact factor of 3.572.
Conclusion: A similar proportion of clinical versus operational research output was found. However, an uneven
distribution across Africa was observed with only six countries accounting for over half of the research output. The
research conducted was of moderate to high quality, with 62% being published in journals with 2010 impact
factors greater than two. Urgent attention should be given to the development of research capacity in low
performing countries around Africa, with increased focus on the process of turning immunisations programme
research evidence into policy and practice, as well as increased focus on issues relating to vaccine financing and
sustainability in Africa.
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Immunisations is one of the most cost-effective public
health interventions that have resulted in significant re-
ductions in global child morbidity and mortality [1]. The
focus of immunisations in low- and middle-income coun-
tries (LMICs) has been the Expanded Programme on
Immunisations (EPI), which was launched in 1974 by the
World Health Organisation (WHO) following the success-
ful programme for the eradication of smallpox [2]. The
programme consisting of scheduled vaccination visits free
of charge for children less than one year of age is operated
by the Ministries of Health in respective countries and
supported in some cases by international agencies such as
WHO, the United Nations Children Fund (UNICEF)
and the Global Alliance for Vaccines and Immunisations
(GAVI), as well as various other donor agencies. National
EPI’s function as a series of inter-related components (i.e.
vaccine supply and quality, surveillance, management,
communication and advocacy, logistics and capacity
building) that aim to improve immunisations coverage
and reduce child morbidity and mortality [3].
While combined global, regional, and national efforts
over the past four decades to improve EPI have resulted
in the global coverage with the third dose of diphtheria-
tetanus-pertussis vaccine by 12 months of age (DTP3)
reaching 85% in 2010, the WHO African Region reached
only 77% in 2010 [4-8]. As Africa continues to address
programmatic and policy issues related to improving
childhood immunisations, it is necessary for the deve-
lopment, adaptation and implementation of all inter-
ventions (programme activities, new vaccines and new
strategies) to continue to be informed by the best avail-
able local evidence [9-12]. As such, the increase in child-
hood immunisations coverage in Africa over the years
should have been accompanied by similar growth in
available childhood immunisations literature. A recent
bibliometric analysis assessed factors associated with
childhood immunisations research productivity in Africa
and found no association between research productivity
and immunisations coverage. In addition, the study
found immunisations research productivity in Africa
to be highly skewed, with private health expenditure
(possibly reflecting country economic status) having a
statistically significant positive association with immuni-
sations research productivity [3]. Africa’s contribution to
the global research on childhood immunisations has
been minimal [3].
We recognise that emphasising the general need
for increased research on childhood immunisations in
Africa without assessing and identifying exactly what
areas of research are lacking would be counter-
productive. As a first step to improving this situation,
we need detailed information on the type of research
that is being conducted in Africa.The objective of this study was to map the evidence
base of published literature on childhood immunisations
research in Africa published in English from 1970 to
2010 in order to ascertain the types and quality of child-
hood immunisations research output on the continent.Methods
Search strategy
We searched two literature databases for relevant peer-
reviewed articles published from January 1, 1970 to
December 31, 2010. These were PubMed and Africa-
Wide databases (Africa-Wide Information-via EBSCO
host combines databases {African Studies, South African
Studies, and African Healthline} to form a multidiscip-
linary aggregation offering unique and extensive coverage
of all facets of Africa and African studies. This resource
is essential for those with an interest in African research,
and information on and about Africa [13]). The develop-
ment and implementation of the search strategy was
conducted by the first author [SM] in consultation with
the other authors [CSW and GH]. We used a com-
bination of MESH (Medical Sub-Headings) terms in
PubMed and key word search terms in Africa-Wide. The
following search phrases were used and combined using
the Boolean operator “AND”: (1) ‘immunisations’ or
‘vaccination’ or ‘immunisations programmes’ (and several
derivatives including ‘immunis’, ‘immuniz’, ‘immunisations
schedule’, ‘vaccine’, ‘vaccinate’, ‘mass vaccination’); (2) the
names of each individual African country were included in
its various forms (for example Mozambique and Mocam-
bique for Mozambique); and (3) ‘infant’ or ‘newborn’ or
‘child’ or ‘children’. For the latter, MESH terms such as
“Infant”, “Newborn” [MESH], “Child, Preschool” [MESH]
were also used in PubMed. Reference lists of selected arti-
cles were searched to identify additional relevant papers.
Only published studies, written in English were included
in this review (due to limited resources as well as the large
outputs obtained from the databases selected). Studies not
conducted in humans were excluded from further analysis.
Duplicate articles obtained in both databases were noted
and only one was included in the final analysis.
The titles and abstracts obtained from the initial
search were reviewed by one author [SM] and verified
by a second author [CSW]. Articles were considered
relevant if they (1) were about immunisations/vaccines
or immunisations programmes and policies; (2) were
studies conducted in Africa; and (3) were studies in chil-
dren. Articles reporting findings from studies of adult
vaccination only, studies not conducted in African popu-
lations or studies merely reporting the epidemiology of
vaccine preventable diseases without specific reference
to vaccination programmes were excluded. A total of 53
African countries were considered for this analysis
Machingaidze et al. BMC Health Services Research 2014, 14:52 Page 3 of 8
http://www.biomedcentral.com/1472-6963/14/52(regardless of classification by WHO into African or
Eastern Mediterranean Regions).
Article review and analysis
The full text of relevant publications was obtained on-
line (if available), from the University of Cape Town’s
Health Science Library, or from the inter-library loan
request service of the Health Science Library. If the full
text was not obtained via these sources, the article was
classified as ‘not found’. Full text articles were reviewed
by one author [SM], and data from selected articles were
abstracted using a standardised data extraction form
designed in consultation with all authors. Abstracted in-
formation was then entered into a Microsoft Access
database designed and managed by SM. All study types
were eligible for inclusion (descriptive, qualitative and
intervention studies). Studies were classified as either
‘Clinical Research’ (clinical trials phase one to four; bur-
den of disease/epidemiology; other clinical studies) or
‘Operational Research’ (programme management; policy;
vaccine financing). Once entered into the database and
classified accordingly by one author, a random sample of
100 articles from the database was assessed by all
authors to ensure correct classification of studies.
Quality of research
A study published in a journal with an impact factor of
greater than zero but less than two was said to be of
‘moderate quality’; a journal with an impact factor of
two to five was said to be of ‘good’ quality; a journal
with an impact factor of five to ten of ‘very good’ quality;
and any journal with an impact factor greater than ten
of ‘excellent’ quality. This classification was produced by
the authors as a proxy for measuring the quality of
research.
Results
Our searches yielded 5436 articles; 1897 articles from
PubMed and 3539 articles from Africa-Wide (Figure 1).
Initial review of titles from both databases identified
2007 articles as potentially relevant while 3429 were
deemed not relevant and excluded. After review of the
2007 abstracts, a further 681 articles were excluded. The
main reasons for exclusion at this stage were: study not
conducted in Africa and study not published in English.
A total of 1326 articles were identified as relevant from
the two databases. From these, 365 articles were identi-
fied as duplicates. The full text of 113 articles were ‘not
found’, resulting in a total of 848 full text articles being
included in the analysis presented in this study.
Distribution of studies
A progressive increase in the total volume of childhood
immunisations research output in Africa was observedwith each successive decade: 55/848 (6 · 5%) from 1970
to 1980; through 178/848 (21%) from 1981 to 1990 and
284/848 (33 · 5%) from 1991 to 2000; to 331/848 (39%)
from 2001 to 2010. The last two decades were found to
be the most productive with 615/848 (72%) of the re-
search output analysed here being published between
1991 and 2010.
Included studies were conducted in 48 African countries
(Figure 2). The six top ranking countries with regards to
childhood immunisations research studies included in this
analysis were: South Africa (n = 182, 21%), The Gambia
(n = 89, 10%), Nigeria (n = 84, 9%), Senegal (n = 53, 6%),
Guinea-Bissau (n = 48, 5%), and Kenya (n = 44, 5%). These
six countries combined accounted for 56% of the total re-
search output included in this analysis.
Classification of studies
A similar proportion of clinical versus operational re-
search output was found. A total of 417/848 (49%) articles
were classified as clinical research. Of these, 168 (40%)
were clinical trials (phase one to phase four); 149 (36%)
were other clinical studies (largely studies assessing im-
mune response to various licensed vaccines or adverse
events following immunisations); and 100 (24%) were bur-
den of disease or epidemiology studies on diseases tar-
geted by traditional and newly introduced EPI vaccines. A
total of 431/848 (51%) articles were classified as opera-
tional research. Of these, 332 (77%) related to vaccine
programme management (largely studies assessing vaccine
coverage, service delivery and logistics, management, as
well as communication and advocacy); 78 (18%) were po-
licy related; and 21 (5%) were related to vaccine financing.
This classification of studies is shown in Table 1.
Our analysis shows that over the past four decades mea-
sles was the leading vaccine-preventable disease studied by
researchers in and around Africa. Of the 848 articles, half
(426) were studies on four diseases: 206 (24%) were on
measles, 77 (9%) on poliomyelitis, 75 (8 · 8%) on tubercu-
losis [bacille Calmette-Guérin (BCG)] and 68 (8%) on hepa-
titis B. Of the remaining half, 135 (16%) were studies on
nine other vaccine-preventable diseases namely: 31 (3 · 7%)
on meningococcal disease, 27 (3 · 2%) on Haemophilus
influenzae type b (Hib), 24 (2 · 8%) on pneumococcal dis-
ease, 16 (1 · 9%) on neonatal tetanus, 14 (1 · 7%) on pertus-
sis, 10 (1 · 2%) on diarrhoea and 12 (1 · 4%) on yellow
fever, diphtheria and smallpox. A small proportion of
studies (n = 27, 3 · 2%) were on integration of EPI to pro-
vide other primary care services, and 260 (31%) targeted
multiple vaccine-preventable diseases with more than one
vaccine given in each study.
Quality of research
Studies were published in 152 different journals. The im-
pact factors of the journals ranged from 0.192 to 53.29.
Number of abstracts reviewed
(n=2007)
Total number of full text articles
included in analysis
(n=848)
Number of duplicates excluded
(n=365)
Total number selected for full text review
(n=1326)
Total (n=5436)
PubMed (1897) + Africa-Wide (3539)
Number excluded after
screening titles
(n=3429)
Number excluded after screening abstracts
(main reasons: study not conducted in
children, study not conducted in Africa and
study not in English)
(n=681)
Number of full text not found 
(n=113)
Figure 1 Study selection process.
Machingaidze et al. BMC Health Services Research 2014, 14:52 Page 4 of 8
http://www.biomedcentral.com/1472-6963/14/52The median impact factor was found to be 3.572. The
2010 impact factor for 41/152 (27%) journals was not
found or the journal did not have an impact factor; 37/
152 (24%) had an impact factor greater than zero to two;
51/152 (34%) from greater than two to five; 14/152 (9%)
from greater than five to ten; and 9/152 (6%) had an im-
pact factors greater than ten. The journals, total number
of publications from that journal, as well as the 2010 im-
pact factors for the 15 journals with the highest number
of publications are listed in Table 2. The South African
Medical Journal was found to have the highest number
of articles (101 articles; 2010 journal impact factor
1.676), followed by Vaccine (82 articles; 2010 impact fac-
tor 3.572), The Lancet (69 articles; 2010 impact factor
33.633), Journal of Infectious Diseases (51 articles; 2010
impact factor 6.288), Bulletin of the World Health
Organisation (41 articles; 2010 impact factor 5.459) andthe Pediatric Infectious Diseases Journal (34 articles;
2010 impact factor 3.064). Figure 3 shows the distribu-
tion of publications in different journals with varying im-
pact factors.
Discussion
This study identified several trends regarding the types
and quality of childhood immunisations research output
in Africa over the past four decades. An important fin-
ding from this study was the even distribution between
clinical versus operational research. Childhood immuni-
sations programmes are a combination of several dif-
ferent components which in turn means that efforts to
address programmatic and policy issues related to the
improvement of these programmes must continue to be
informed by both clinical and operational evidence. The
development of an efficacious and effective vaccine
Figure 2 Distribution of childhood immunisations publication across Africa.
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sations programme to ensure prompt and safe delivery
of the vaccine to all children (operational research) is
suboptimal and will result in under-vaccinated and un-
vaccinated children.
An important component of health systems streng-
thening regarding childhood immunisations programmes
is the efficient translation of research findings into policy
and practice. Only a small proportion (18%) of studiesTable 1 Classification of selected studies
Categories Number of studies (%)
Clinical research 417
Clinical trials (Phases1-4) 168 (40%)
Burden or disease/epidemiology 100 (24%)
Other clinical studies 149 (36%)
Operational research 431
Programme management 332 (77%)
Policy 78 (18%)
Vaccine financing 21 (5%)classified as operational research addressed policy issues
on childhood immunisations, with the majority of the
articles having been written by authors with South
African affiliation and published in the South African
Medical Journal. African countries need to pay urgent at-
tention to ensuring that sufficient policy-related research
is conducted to ensure that individual country childhood
immunisations policies are informed by current and rele-
vant research evidence.
Another important aspect with regards to immunisa-
tions systems strengthening in Africa is that of vaccine/
immunisations financing. In a recent report, Médecins
Sans Frontieres (MSF) highlights that vaccine procure-
ment and pricing strategies, as well as vaccine adaptation
to suit low and middle income countries (LMICs) remain
essential components of helping to strengthen immunisa-
tions systems across Africa [14]. With the cost per live
birth for immunisations in LMICs expected to increase
from US$25 for traditional EPI vaccines (including hepa-
titis B and Hib vaccines) to US$58 if pneumococcal conju-
gate vaccine (PCV) and rotavirus vaccine are added to the
schedule [2], vaccine financing should remain high on the
Table 2 Top 15 journals and their impact factors with
African researchers as first authors
Journal TP* 2010 IF*
South African Medical Journal 101 1.676
Vaccine 82 3.766
The Lancet 69 33.633
Journal of Infectious Diseases 51 6.288
Bulletin of the World Health Organization 41 5.459
Pediatric Infectious Diseases Journal 34 3.577
Royal Society of Tropical Medicine and Hygiene 29 2.615
Journal of Tropical Pediatrics 28 1.388
East African Medical Journal 28 n/a
International Journal of Epidemiology 25 6.414
Tropical Medicine and International Health 18 2.795
Annals of Tropical Paediatrics 18 0.9
Social Science & Medicine 13 2.699
Central African Journal of Medicine 12 n/a
British Medical Journal 11 13.471
*TP = Total Publications out of 848; IF = Impact Factor; *n/a - 2010 impact
factor was not found online or the journal did not have an impact factor.
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5% of studies classified as operational research addressed
vaccine financing in Africa, suggesting that there is room
for much improvement in this area.
Similar to the findings of a bibliometric analysis [3] of
childhood immunisations research productivity in Africa
from 1974 to 2010, we found that the distribution of
childhood immunisations research across Africa was
highly skewed with six countries (South Africa, The
Gambia, Nigeria, Senegal, Guinea-Bissau and Kenya) ac-
counting for slightly over half of the total research out-
put analysed. This highly uneven distribution across
Africa is a reflection of the limited and under-developed
research capacity in most African countries. Multiple
medical schools, public health schools as well as local
and international health research institutions present inFigure 3 Proportion of publications with varying impact factors.the above mentioned six countries are a likely explan-
ation of the high volumes of childhood immunisations
research when compared to other African countries.
However, it is important to note that although it is be-
yond the scope of this paper, the individual country eco-
nomic development status (amongst other individual
country characteristics) is likely to influence research
productivity as some countries have far more resources
and increased capacity to both conduct research and im-
plement findings when compared to others [3,15,16].
We identified measles as the leading vaccine-preven-
table disease targeted by African researchers over the past
four decades and this is not surprising as it was the lead-
ing cause of infant and child mortality in Africa for many
years. Greater research attention was also given to polio-
myelitis, tuberculosis [bacille Calmette-Guérin (BCG)]
and hepatitis B when compared to other vaccine-preven-
table diseases. Childhood immunisations research focus is
likely to have shifted and will shift in future according to
burden of disease as well as child mortality patterns in
Africa. In a recent publication on causes of global child
mortality as of 2010, pneumonia was identified as the
leading cause of death contributing 18% all-cause morta-
lity in children under 5 years compared to measles (1%),
diarrhoea (11%) and malaria (7%) [17]. The volume of re-
search in Africa on childhood immunisations in relation
to pneumonia (PCV vaccine, Hib vaccine) and diarrhoea
(rotavirus vaccine), amongst other diseases, has increased
in recent years and will continue to do so as current
epidemiological patterns demand attention be shifted to
these leading child killer diseases [18,19].
EPI in Africa may very well be the most successful
health programme on the continent, and is thus ideal for
providing add-on services for improving health status of
young children and mothers [6,20,21]. A small propor-
tion of studies included in this analysis (3.2%) related to
the integration of other primary health care services to
EPI. This integration of services such as the distribution
of insecticide-treated bed nets, vitamin A supplementa-
tion, and deworming of children, is likely to improve as
immunisations programmes around Africa become
stronger and better able to facilitate additional interven-
tions besides scheduled vaccines. However, accomplish-
ing this expanded agenda will require a firm
commitment from African governments both politically
and financially [22]; and will also require governments
and their development partners to establish efficient
mechanisms to facilitate this expansion in their respect-
ive primary health care systems [20-23].
The quality of research is difficult to measure. Impact
factors provide a measure of the frequency peer-reviewed
journal articles are cited by other researchers as well as a
yearly measure of the comparative importance of a journal
in relation to other journals in its field. We used impact
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immunisations research in Africa, where studies published
in journals with higher impact factors were said to be of
higher quality. In general, the majority of articles were of
‘good’ quality (i.e. impact factor of two to five), while
smaller proportions were of ‘very good’ and ‘excellent’
quality (i.e. impact factors of five and above).
There were several limitations to the analysis pre-
sented here. We acknowledge that by searching only two
databases we may have missed out on relevant articles
indexed in other databases. In addition, not all local
country journals are indexed in PubMed and Africa-
Wide, meaning studies published in these non-indexed
journals may have been missed. An assessment of
the grey literature with regards to immunisations pro-
grammes was not included as part of this review. This
means that relevant operational and policy-related docu-
ments in the grey literature were not included in this
analysis [24-26]. Due to limited resources, studies pub-
lished in languages other than English were excluded. In
addition, due to the broad nature of childhood immu-
nisation (encompassing many different components)
identifying a search strategy that includes all aspects of
childhood immunisations was challenging. Quality of re-
search was assessed using journal impact factors classi-
fied by the authors as a proxy, and this may not be an
accurate reflection of the true quality of the individual
studies. Despite these limitations, we believe that this
analysis is still sufficient to provide a representative and
much needed evidence base of the types and quality of
childhood immunisations research in Africa over the
past four decades.
African countries and international agencies assisting
Africa should prioritise operational research in the context
of GAVI and the Decade of Vaccines/Global Vaccine Ac-
tion Plan (GVAP). The mission of the GVAP is to extend,
by 2020 and beyond, the full benefits of immunisations to
all people, regardless of where they are born, who they are
or where they live. The plan calls for creation of a robust
research and development environment for immunisa-
tions, and urges academia to “engage more with system-
atic reviews to identify areas where solid scientific
evidence exists (which should be the basis of health pol-
icies) and those areas where such evidence is lacking
(which would be the basis for future primary research)”.
Examples of systematic reviews could include understand-
ing interventions for improving routine immunisations
coverage, the effects of mass vaccination campaigns on
routine immunisations services, financial arrangements
for immunisations and other primary healthcare pro-
grammes, and the effectiveness of interventions for
expanding routine immunisations services beyond child-
hood. Beyond systematic reviews of global evidence, there
is need for local evidence on perceptions, needs, valuesand preferences of immunisations stakeholders as well as
socio-cultural and religious factors affecting immunisa-
tions in African communities.
Conclusion
While a progressive increase in the volume of childhood
immunisations research output was observed with each
successive decade since 1970, the last two decades (1991–
2010) were found to be the most productive. An even dis-
tribution between clinical versus operational research was
found with regards to childhood immunisations research
output in Africa. However, the distribution of studies
across Africa was found to be highly skewed, with six
countries (South Africa, The Gambia, Nigeria, Senegal,
Guinea-Bissau and Kenya) accounting for half of the total
research output. Measles was found to be the leading
vaccine-preventable disease studied by African authors
over the past four decades. Research was of moderate to
excellent quality, with 62% being published in journals
with impact factors greater than two. Urgent attention
should be given to the development of research capacity
in low performing countries around Africa, with increased
focus on the process of turning immunisations programme
research evidence into policy and practice, as well as in-
creased focus on issues relating to vaccine financing and
sustainability in Africa.
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